Capital Research Global Investors Liva Nova PLC Transaction History
Capital Research Global Investors
- $440 Billion
- Q1 2025
A detailed history of Capital Research Global Investors transactions in Liva Nova PLC stock. As of the latest transaction made, Capital Research Global Investors holds 2,078,430 shares of LIVN stock, worth $105 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,078,430
Previous 1,612,818
28.87%
Holding current value
$105 Million
Previous $74.7 Million
9.31%
% of portfolio
0.02%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding LIVN
# of Institutions
274Shares Held
55.3MCall Options Held
72.5KPut Options Held
67.9K-
Black Rock Inc. New York, NY6.9MShares$350 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.64MShares$235 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$124 Million0.0% of portfolio
-
State Street Corp Boston, MA2.1MShares$106 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.07MShares$105 Million0.05% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.71B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...